Hualan Biological Engineering Inc. (SHE:002007)

SHE:002007 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Cash & Equivalents	1,687	1,367	993.77	1,099	692.54	1,038
Trading Asset Securities	2,389	1,888	2,115	2,369	2,659	2,986
Cash & Short-Term Investments	4,076	3,255	3,109	3,468	3,352	4,024
Cash Growth	55.49%	4.70%	-10.36%	3.47%	-16.72%	19.38%
Accounts Receivable	2,217	2,052	2,590	2,410	2,097	2,263
Other Receivables	16.78	18.66	6.95	4.84	7.05	10.45
Receivables	2,234	2,071	3,297	2,759	2,104	2,274
Inventory	2,288	2,029	1,674	1,447	1,359	1,175
Other Current Assets	1,450	2,262	1,247	403.56	36.67	39.31
Total Current Assets	10,049	9,616	9,327	8,077	6,851	7,512
Property, Plant & Equipment	2,964	2,964	2,727	2,290	2,338	1,769
Long-Term Investments	35.42	3,023	3,273	3,673	1,716	110.36
Goodwill	-	-	1.1	1.1	1.1	1.1
Other Intangible Assets	318.94	319.04	319.72	310	204.53	195.24
Long-Term Deferred Tax Assets	225.99	235.34	241.72	232.49	201.25	186.08
Long-Term Deferred Charges	55.9	59.69	59.6	42.49	55.42	47.13
Other Long-Term Assets	2,618	92.74	157.3	116.8	170.16	218.04
Total Assets	16,267	16,310	16,106	14,743	11,537	10,039
Accounts Payable	210.55	217.16	197.26	175.49	241.03	162.52
Accrued Expenses	0.42	914.99	1,169	1,071	947.5	971.14
Short-Term Debt	447	899.73	700.35	800.38	800.7	400
Current Portion of Long-Term Debt	-	-	300	-	10.18	-
Current Portion of Leases	0.37	0.37	0.36	0.44	-	-
Current Income Taxes Payable	50	19.58	63.36	9.7	48.71	180.02
Current Unearned Revenue	10.16	13.46	8.57	14.78	8.28	7.16
Other Current Liabilities	2,208	294.83	142.3	76.53	158.53	195.74
Total Current Liabilities	2,926	2,360	2,581	2,148	2,215	1,917
Long-Term Debt	-	-	-	300	190	-
Long-Term Leases	8.31	8.78	9.15	9.3	-	-
Long-Term Unearned Revenue	49.14	54.18	51.18	54.37	57.91	17.35
Long-Term Deferred Tax Liabilities	34.29	40.14	42.82	20.87	10.37	4.29
Total Liabilities	3,018	2,463	2,685	2,533	2,473	1,938
Common Stock	1,827	1,829	1,829	1,824	1,824	1,824
Additional Paid-In Capital	1,424	1,430	1,486	1,415	105.62	101.96
Retained Earnings	8,138	8,633	8,093	7,159	6,448	5,696
Treasury Stock	-17.95	-32.72	-48.07	-	-40.59	-93.75
Total Common Equity	11,372	11,859	11,359	10,398	8,337	7,529
Minority Interest	1,878	1,988	2,062	1,812	727.09	571.87
Shareholders' Equity	13,250	13,847	13,421	12,210	9,064	8,100
Total Liabilities & Equity	16,267	16,310	16,106	14,743	11,537	10,039
Total Debt	455.68	908.88	1,010	1,110	1,001	400
Net Cash (Debt)	3,621	2,346	2,099	2,358	2,351	3,624
Net Cash Growth	94.44%	11.77%	-10.99%	0.30%	-35.14%	7.52%
Net Cash Per Share	1.98	1.28	1.15	1.29	1.28	1.99
Filing Date Shares Outstanding	1,827	1,829	1,829	1,824	1,824	1,824
Total Common Shares Outstanding	1,827	1,829	1,829	1,824	1,824	1,824
Working Capital	7,123	7,256	6,745	5,929	4,636	5,595
Book Value Per Share	6.22	6.48	6.21	5.70	4.57	4.13
Tangible Book Value	11,053	11,540	11,039	10,087	8,131	7,332
Tangible Book Value Per Share	6.05	6.31	6.04	5.53	4.46	4.02
Buildings	-	1,717	1,302	1,206	1,256	1,032
Machinery	-	2,639	2,504	2,383	2,433	1,688
Construction In Progress	-	552.48	661.51	216.39	132.96	379.44

Source: S&P Global Market Intelligence. Standard template. Financial Sources.